Lance Baldo, Chief Medical Officer at Adaptive Biotechnologies Corp (ADPT), sold 12,300 shares at $47.29 ($582K) on 2020-07-06, disclosed to the SEC on 2020-07-08.
Open-market sale of $582k ADPT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.29 | 6,050 | $286K | 49.2% |
| 2 | $47.29 | 6,050 | $286K | 49.2% |
| 3 | $48.42 | 200 | $10K | 1.7% |
| Total | $47.31 avg | 12,300 | $582K | 100% |
| Filing → |
| ADPT | SELL | 2021-04-16 | $89K | — | Filing → |
| ADPT | SELL | 2021-01-29 | $4.7M | — | Filing → |
| ADPT | SELL | 2020-12-09 | $442K | — | Filing → |